Find this article useful?
Why not sign up to our mailing list and receive regular articles and tips about IBD to your inbox?
TAKE ACTION: http://action.crohnsandcolitis.ca/choice
Canadian governments are considering or implementing health policy that will switch patients doing well on a biologic to a biosimilar for non-medical reasons. We spoke to Dr. David Armstrong about the impact of a non-medical switch and why treatment decisions should be made by patients and their doctors.
ABOUT THE SPEAKER
Dr. David Armstrong is the Past President and Current Board Member of the Canadian Association of Gastroenterology. He is also a Professor in the Division of Gastroenterology at McMaster University.
Crohn’s and Colitis Canada is the only national, volunteer-based charity focused on finding the cures for Crohn’s disease and ulcerative colitis and improving the lives of children and adults affected by these diseases.
Why not sign up to our mailing list and receive regular articles and tips about IBD to your inbox?
Warning: Undefined variable $num_comments in /mnt/vhosts/ibdrelief.com/httpdocs/modules/comments.php on line 3
Comment
Warning: Undefined variable $num_comments in /mnt/vhosts/ibdrelief.com/httpdocs/modules/comments.php on line 3
s